Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Assets (2016 - 2025)

Historic Return on Assets for Ascendis Pharma A (ASND) over the last 11 years, with Q3 2025 value amounting to 0.18%.

  • Ascendis Pharma A's Return on Assets rose 2600.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.37% for FY2024, which is 1500.0% up from last year.
  • Per Ascendis Pharma A's latest filing, its Return on Assets stood at 0.18% for Q3 2025, which was up 2600.0% from 0.24% recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Return on Assets ranged from a high of 0.18% in Q3 2025 and a low of 0.68% during Q3 2023
  • Its 5-year average for Return on Assets is 0.42%, with a median of 0.41% in 2021.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -3500bps in 2023, then skyrocketed by 3700bps in 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Assets (Quarter) stood at 0.24% in 2021, then crashed by -104bps to 0.5% in 2022, then fell by -11bps to 0.55% in 2023, then surged by 41bps to 0.32% in 2024, then soared by 44bps to 0.18% in 2025.
  • Its Return on Assets was 0.18% in Q3 2025, compared to 0.24% in Q2 2025 and 0.3% in Q1 2025.